MethotrexatePneumocystis jirovecii pneumonia: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2026卷 / 1期

关键词：

D O I：

10.1007/s40278-024-67051-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：188 / 188

相关论文

共 50 条

[31] RituximabPneumocystis jirovecii pneumonia: case report
Reactions Weekly, 2020, 1795 (1) : 239 - 239
[32] ImmunosuppressantsPneumocystis jirovecii pneumonia: case report
Reactions Weekly, 2015, 1579 (1) : 221 - 221
[33] PembrolizumabPneumocystis jirovecii pneumonia: case report
Reactions Weekly, 2022, 1915 (1) : 363 - 363
[34] Antineoplastics/immunosuppressantsPneumocystis jirovecii pneumonia: case report
Reactions Weekly, 2020, 1814 (1) : 74 - 74
[35] Antineoplastics/methylprednisolonePneumocystis jirovecii pneumonia: case report
Reactions Weekly, 2019, 1751 (1) : 47 - 47
[36] Mycophenolate/tacrolimusPneumocystis jirovecii pneumonia: case report
Reactions Weekly, 2021, 1840 (1) : 304 - 304
[37] DexamethasoneFatal Pneumocystis jirovecii pneumonia: case report
Reactions Weekly, 2013, 1445 (1) : 19 - 19
[38] Methotrexate/prednisonePneumocystis jirovecii pneumonia: case report
Reactions Weekly, 2022, 1892 (1) : 151 - 151
[39] Bendamustine/rituximabPneumocystis jirovecii pneumonia : case report
Reactions Weekly, 2017, 1663 (1) : 61 - 61
[40] PralsetinibPneumocystis jirovecii pneumonia and neutropenia: case report
Reactions Weekly, 2025, 2054 (1) : 378 - 378

← 1 2 3 4 5 →